InMed Pharmaceuticals Inc. Common Shares (INM) Stock Price, Quote & AI Analysis
Live INM stock price, real-time charts, AI-powered analysis, technical analysis, earnings insights, and market sentiment for InMed Pharmaceuticals Inc. Common Shares.
TradeVae provides AI-driven analysis and real-time market intelligence for InMed Pharmaceuticals Inc. Common Shares (INM), including price action, technical indicators, earnings performance, analyst sentiment, and risk-aware market context.
AI Analysis
Explore comprehensive AI-powered analysis including summary insights, bull and bear cases, key risks, and factors to watch.
Generating AI analysis...
InMed Pharmaceuticals Inc. Common Shares's fundamentals reflect its scale, profitability, and position within the global technology sector. Key valuation and financial metrics are summarized below, followed by detailed financial statements.
InMed Pharmaceuticals Inc. Common Shares Overview
Company information
Company Overview
InMed Pharmaceuticals, Inc. is a pharmaceutical drug development company, which engages in developing small molecule drug candidates that are preferential signaling ligands of the endogenous CB1 and CB2 receptors as well as other receptor targets linked to human disease. The company was founded by Christopher Bogart, Sazzad Hossain, Hyder A. Khoja, and Craig D. Schneider on May 19, 1981 and is headquartered in Vancouver, Canada.
Company Details
Technical Indicators
Key technical analysis metrics and indicators
Loading technical indicators...
Valuation Metrics
Key valuation ratios and comparisons
Loading valuation metrics...
InMed Pharmaceuticals Inc. Common Shares Earnings & Financial Statements
Earnings Calendar
Upcoming earnings dates and historical surprises
Loading earnings calendar...
Financial Statements
Income statements, balance sheets, and cash flow
Loading income statements...
Loading balance sheets...
Loading cash flow statements...